Argonne, Ill.
The University of Chicago will begin construction in fall 2005 on the $31-million Howard T. Ricketts Laboratory, a germ research facility to be located at Argonne National Laboratory, which the University manages for the federal government. The 35,000-sf BSL-3 laboratory will accommodate research on vaccines, drug treatments, and diagnostic testing for infectious diseases. Slated to open in 2008, the facility will employ 50 to 80 people and will support research for the new Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research.
